Clinical Trial: Polycystic Liver Disease in Kidney Transplant

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: Single Center, Open-label Randomized Prospective Trial: Effect of Sirolimus on Polycystic Liver Disease

Brief Summary: The purpose of this study is to see if one kind of immunosuppressive drug has better effects for the patient's polycystic liver disease than another type. Tacrolimus and Sirolimus are the two immunosuppressive drugs that will be compared for this study. Both drugs have been commonly prescribed to prevent rejection.